Levetiracetam Tablet, Film Coated
Product Images NDC 70518-1772

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-1772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Levetiracetam 500 mg film-coated tablets packaging label showing quantity of 30 tablets. The label includes the RemedyRepack Inc. logo, NDC number 70518-1772-00, manufacturer Lupin Pharma in Baltimore, MD, and storage instructions. The label also indicates the product is prescription only.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01

A formula for calculating total daily dose of medication, expressed as (Daily dose in mg per kg per day) multiplied by (patient weight in kg), divided by 100 mg per mL. This calculation determines the total daily dose in mL per day.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02

A text panel showing formulas for calculating creatinine clearance (CLcr), including adjustments for age, weight, serum creatinine, and body surface area, with a specific factor for female patients.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03

Chemical structure diagram of levetiracetam, the active ingredient, showing its molecular framework with a pyrrolidone ring, ethyl side chain, and amide group.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04

A bar chart showing the percentage of patients across three groups: Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). The y-axis represents the percentage of patients from 0% to 45%, with higher values for the Levetiracetam groups compared to placebo.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05

A bar chart depicting the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The percentages are approximately 6.3% for placebo, 20.8% for Levetiracetam 1000 mg/day, and 35.2% for Levetiracetam 2000 mg/day, indicating increasing effect with higher dosages.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06

A bar graph comparing the percentage of patients between two groups: Placebo (N=104) with 14.4% and Levetiracetam 3000 mg/day (N=180) with 39.4%, displayed on the vertical axis labeled '% of Patients.'*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07

A bar graph comparing the percentage of patients in two groups: Placebo (N=97) and Levetiracetam (N=101). The graph shows 19.6% of patients in the Placebo group and 44.6% in the Levetiracetam group, with the y-axis labeled as '% of Patients.'*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08

Bar chart comparing the percentage of patients in two groups: Placebo (N=51) with 19.6% and Levetiracetam (N=58) with 43.1%. The y-axis represents the percentage of patients ranging from 0% to 45%.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09

A bar chart comparing the percentage of patients responding to Placebo versus Levetiracetam. Placebo group with 84 patients shows a 45.2% response rate, while the Levetiracetam group with 79 patients shows a 72.2% response rate, marked with an asterisk indicating statistical significance.*

FDA Label Image

Levetiracetam 500mg 70518 1772 01

Levetiracetam 500 mg film-coated tablet label displaying the product name, strength, and quantity of 60 tablets. The label indicates the medication is prescription-only and repackaged by RemedyRepack Inc. It includes storage instructions and manufacturer information, Lupin Pharma, Baltimore, MD.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.